"Anything that won't sell, I don't want to invent. Its sale is proof of utility, and utility is success." Thomas A. Edison (1847-1931).

A new Munich-based company that says its patented technologies can reduce household water consumption by 90 per cent on average is looking for more investment.

Every cloud has its silver lining. So if it wasn't for his daughter's diabetes, Anders Essen-Möller might not have sold his company and started Diamyd Medical AB.

A British pharmaceutical distributor, Beckpharma Ltd., said it licensed two Cuban healthcare products to sell in Europe as part of a broader effort for trade links.

Some strange new ways of raising money are starting to emerge - but would-be borrowers and lenders are still making sense of them.

New regulations on the registration and testing of chemicals could have some problematic knock-on effects on European R&D – but they could also bring some lucrative work the way of contract research organisations.

A new proposal from the European Investment Fund seeks to accelerate the success of European technology transfer projects. A noble idea, says Mary Lisbeth D'Amico in her fortnightly column, but no one has yet stepped up to foot the bill.